TRU (TRU)
Quantitative Summary
DeterministicStrong operational fundamentals (Piotroski 8/9) with Altman Z of 2.3.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe underlying economics exhibit a robust balance sheet profile characterized by a Piotroski F-Score of 8/9 and a negative Beneish M-Score of -2.66, signaling strong fundamental quality with minimal earnings manipulation risk. The DuPont decomposition reveals that the 10% return on equity is primarily driven by operational leverage rather than asset efficiency; while net margins sit at an attractive 10%, this is offset by a modest 0.41x asset turnover rate and elevated financial leverage of 2.44x, which dilutes free cash flow generation despite the high gross margin of 59.1%. Although revenue growth remains steady at 9.4% year-over-year, the return on invested capital stands at only 7%, indicating that the current equity multiplier is necessary to achieve the reported ROE but may constrain long-term organic expansion potential relative to industry peers with higher asset efficiency.
Valuation metrics suggest a significant premium over intrinsic value, as the current price-to-earnings ratio of 28.7x exceeds typical multiples for firms with similar growth trajectories and margin profiles. While the DCF model implies a fair value of $68, suggesting substantial upside if market assumptions regarding future cash flows hold true, the high multiple indicates that investors are already pricing in aggressive long-term growth expectations not fully reflected in current fundamentals. The divergence between the 9% revenue growth rate and the steep valuation compression risk highlights a potential mean reversion scenario where earnings power must accelerate to justify existing share prices without further leverage or margin expansion.
Insider activity presents a notable counterweight to the positive fundamental scores, with $1,038,464 in net selling over the past 90 days. This consistent outflow by management could signal concerns about near-term valuation levels or capital allocation priorities that differ from retail sentiment, introducing an element of uncertainty regarding future insider confidence despite the company's strong historical financial integrity scores.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 10.1% | 12.1% | 14.1% |
|---|---|---|---|
| 2% | $83 | $61 | $46 |
| 3% | $95 | $68 | $50 |
| 4% | $111 | $77 | $56 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=12.1%, terminal growth 3%. Fair value $68 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like MDYG or SPMD, the fund manager is mechanically forced to buy or sell TRU shares regardless of TRU's individual fundamentals. We estimate $832M of passive capital is structurally linked to TRU through 8 tracked ETFs. Passive flows have a limited but growing influence on TRU's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in TRU to visualize passive redemption contagion across ETFs and collateral stocks.
If TRU (TRU) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies FLEX LTD (FLEX) as the most exposed collateral stock, sharing 2 ETFs with TRU. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 15 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
TRU Ownership Dynamics
ETFs with Highest TRU Exposure
Float lock-up computed from 19 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
TRU Capital Efficiency
How efficiently does TRU convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
TRU converts 46% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 54% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-5.1%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-06 | 116,872 | $68.24 | $8.0M |
| 2026-04-27 | 386 | $72.61 | $28,027.46 |
| 2026-04-24 | 1,374 | $73.08 | $100,411.92 |
| 2026-04-20 | 13 | $78.25 | $1,017.25 |
| 2026-04-09 | 26 | $71.20 | $1,851.2 |
| 2026-03-27 | 6,490 | $68.24 | $442,877.6 |
| 2026-03-26 | 2,990 | $67.72 | $202,482.8 |
| 2026-03-25 | 61,170 | $68.62 | $4.2M |
| 2026-03-23 | 2,885 | $70.55 | $203,536.75 |
| 2026-03-19 | 12 | $73.05 | $876.6 |
| 2026-03-18 | 71,336 | $73.66 | $5.3M |
| 2026-03-17 | 13,268 | $70.71 | $938,180.28 |
| 2026-03-10 | 529 | $76.05 | $40,230.45 |
| 2026-03-03 | 1,114 | $78.31 | $87,237.34 |
| 2026-02-24 | 262 | $71.23 | $18,662.26 |
| 2026-02-23 | 302 | $76.20 | $23,012.4 |
| 2026-02-17 | 2,629 | $73.92 | $194,335.68 |
| 2026-02-05 | 27,617 | $69.50 | $1.9M |
| 2026-02-03 | 2 | $77.21 | $154.42 |
| 2026-01-20 | 200 | $86.22 | $17,244 |
| 2026-01-15 | 44,795 | $85.50 | $3.8M |
| 2026-01-08 | 41 | $83.50 | $3,423.5 |
| 2026-01-06 | 3,502 | $86.95 | $304,498.9 |
| 2025-12-22 | 17,851 | $87.09 | $1.6M |
| 2025-12-12 | 2,933 | $85.76 | $251,534.08 |
| 2025-12-11 | 47 | $84.23 | $3,958.81 |
| 2025-12-09 | 4,146 | $82.01 | $340,013.46 |
| 2025-12-05 | 18,474 | $84.19 | $1.6M |
| 2025-11-26 | 1,762 | $85.10 | $149,946.2 |
| 2025-11-20 | 83 | $81.88 | $6,796.04 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare TRU to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.